1. The concentrations of liver glycogen and plasma D-glucose were measured in caesariandelivered newborn rats at time-intervals up to 3 h after delivery after treatment of the neonatal rats with glucagon, dibutyryl cyclic AMP, cortisol or cortisol+dibutyryl cyclic AMP. Glycogenolysis was promoted by glucagon or dibutyryl cyclic AMP in the third hour after birth but not at earlier times. Cortisol and dibutyryl cyclic AMP together (but neither agent alone) promoted glycogenolysis in the second hour after birth, but no hormone combination was effective in the first postnatal hour. 2. The specific radioactivity of plasma D-glucose was measured as a function of time for up to 75 min after the intraperitoneal injection of D-[6-4C]glucose and D-[6_3H]glucose into newborn rats at delivery and after treatment with glucagon or actinomycin D. Glucagon-mediated hyperglycaemia at this time was due to an increased rate of glucose formation and a decreased rate of glucose utilization. Actinomycin D prevented glucose formation and accelerated the rate of postnatal hypoglycaemia. 3. The specific radioactivity of plasma L-lactate and the incorporation of "4C into plasma D-glucose was measured as a function of time after the intraperitoneal injection of L-[U-14C]lactate into glucagon-or actinomycin D-treated rats immediately after delivery. The calculated rates of lactate formation were unchanged by either treatment, but lactate utilization was stimulated by glucagon administration. Glucagon stimulated and actinomycin D diminished 14C incorporation into plasma D-glucose. 4. The factors involved in the initiation of glycogenolysis and gluconeogenesis in the rat immediately after birth are discussed.
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Immediately after birth the newborn rat utilizes its considerable body pools of glucose and lactate as energy sources until suckling begins and adaptation to the high-fat milk diet is complete (Snell & Walker, 1973) . Towards the end of gestation large stores of hepatic glycogen are built up in the foetal rat (Shelley, 1961; Dawkins, 1963a,b; Greengard & Dewey, 1970) , but there appears to be a lag of 1-2h before significant amounts of the glycogen are mobilized and this may, in part, explain the pronounced hypoglycaemia experienced by the newborn rat shortly after parturition (Snell & Walker, 1973) . Subsequent recovery from the hypoglycaemia coincides with the fall in hepatic glycogen concentration (Snell & Walker, 1973) . Liver glycogen breakdown in the adult rat appears to be effected by activation of x-glucan phosphorylase (EC 2.4.1.1) by the hormone glucagon, acting via cyclic AMP (Exton et al., 1971a,b; Hers et al., 1970; Sutherland & Rail, 1958 , 1960 Rall et al., 1957) . In the present paper we have examined the factors involved in the initiation of glycogenolysis immediately after birth, particularly the role ofglucagon and cyclic AMP at this time. Previously we have reported that soon after birth the newborn rat is capable of synthesizing glucose from endogenous precursors (Snell & Vol. 134 Walker, 1973 ) and so we have also investigated the effect of glucagon on glucose-transfer rates in vivo after injection of [6-14C] (Snell & Walker, 1972a) .
Experimental Materials
Animals. The rats were an albino Wistar strain; foetal ages were determined as previously described (Snell & Walker, 1972b) . Term foetuses (on day 22 of gestation) were delivered surgically by caesarian section and maintained as described by Snell & Walker (1973) .
Chemicals. Dibutyryl cyclic AMP (6-N,2'-Odibutyryladenosine 3': 5'-cyclic monophosphate) was from Boehringer Corp. (London) Ltd., London W.5, U.K.; glucagon was from Eli Lilly and Co. Ltd., Basingstoke, Hants., U.K.; cortisol acetate ('Hydrocortisyl') was from Roussel Laboratories Ltd., London N.W.10, U.K. and actinomycin D was from Calbiochem, London W.1, U.K. The sources of other materials are as given previously (Snell & Walker, 1973 Determination of specific radioactivities oJ plasma glucose and lactate. The separation of plasma glucose and lactate and measurement of radioactivity were as described by Vernon & Walker (1972) . Determination of plasma glucose and lactate concentrations was as described previously (Snell & Walker, 1973) .
Calculations. Statistical calculations and analysis of the data, estimates of metabolite pool sizes and the transfer rates of glucose and lactate were as described previously (Snell & Walker, 1973) .
Results

Glycogen mobilization at birth
In previous work we reported a lag of 1-2h in liver glycogen mobilization after caesarian delivery of term foetuses (Snell & Walker, 1973) . The effect of glucagon or dibutyryl cyclic AMP on liver glycogen mobilization in surgically delivered newborn rats at various times after birth is shown in Table 1 . Neither agent injected at birth had any significant effect on the glycogen concentration measured 1 h later. Glucagon injected at 1 h after delivery may have produced a slight fall in glycogen concentration at 2h post partum, but this was statistically insignificant 451±26(10) 442± 36 (8) 468±18 (6) 462±15 (6) 454±19 (6) 402 ± 20 (6) 386±25 ( Surgically delivered newborn rats were injected intraperitoneally at the time of delivery or 1 h after delivery with 0.9 % NaCI (controls), cortisol acetate (50,ug/rat), dibutyryl cyclic AMP (0.25 mg/rat) or cortisol +dibutyryl cyclic AMP and killed 1 h after injection. Plasma glucose concentration and liver glycogen concentration were determined as described in the text and are given below as the means ±S.E.M. with the number ofdeterminations in parentheses. Glucose concentration was measured in plasma pooled from two animals and glycogen concentration was measured in individual rats. Statistical significance of results, compared with controls: *** P <0.001; ** P <0.01; * P<0.05.
Treatment and age at death Injected at delivery
Control (1 h
Liver glycogen (,mol of glycogen glucose/g of liver)
421±17 (6) 443 ±19 (6) 428±19 (4) 408 ± 20 (6) 409 ± 29 (6) 421± 18 (6) 398± 26 (4) 97±15 (6)*** Concn. of plasma glucose (,umol/ml of plasma) 3.92±0.28 (3) 6.01 ± 0.32 (3)* 10.42 ± 0.47 (2)** 10.36 ± 0.36 (3)*** 2.61 ±0.23 (3) 3.42± 0.24 (3) 10.62 ± 0.34 (2)** 13.16± 0.29 (3)*** (P>0.05). Glucagon or dibutyryl cyclic AMP injected at 2h after delivery, however, both produced a significant and marked fall in glycogen concentration by 3hpQstpartum(P<0.001). ActinomycinD administered simultaneously with dibutyryl cyclic AMP was without effect at birth, and at 2h after delivery the inhibitor did not prevent the glycogenolytic action of dibutyryl cyclic AMP.
Despite the lack of effect of glucagon or dibutyryl cyclic AMP on liver glycogen mobilization in the first 2h after delivery, plasma glucose concentrations were markedly elevated by each agent (P<0.001) ( Table 1) . Actinomycin D administered simultaneously with dibutyryl cyclic AMP at birth blocked the increase in plasma glucose by the cyclic nucleotide (P <0.001). At 2h after delivery glucagon or dibutyryl cyclic AMP both markedly elevated plasma glucose concentrations (P<0.001) but, in contrast, actinomycin D had no effect on this stimulation by dibutyryl cyclic AMP.
There is some evidence for the involvement of adrenal corticosteroids in hormonally induced glycogenolysis in adult rats; adrenalectomy blocks the stimulation of a-glucan phosphorylase by exogenous adrenaline or cyclic AMP in rat liver (Schaeffer et al., 1969a) , skeletal muscle (Schaeffer et al., 1969b) and heart muscle (Miller et al., 1971) . The effect of cortisol on the glycogenolytic response to dibutyryl cyclic AMP at various times after delivery is shown in (117) and, for each experimental situation, the body weight did not vary significantly between the groups of rats killed at each time-interval after injection. The plasma glucose concentration at various times after the injection of radioactive glucose, either alone or simultaneously with glucagon or actinomycin D, is shown in Fig. 1 . Glucose concentration decreased with time in rats injected with labelled glucose alone or together with actinomycin D but remained relatively constant in glucagon-treated rats. Although glucose concentration at the time of injection (by statistical extrapolation to zero time) was not significantly different in rats injected with glucagon, actinomycin D or 0.9% NaCl (P>0.05), the actinomycin D treatment significantly accelerated the development of hypoglycaemia in newborn rats as compared with 0.9 % NaCl-injected controls (P<0.001) (Fig. 1) . The results, plotted as the logarithm of the plasma glucose concentration with time, showed good linearity (P<0.01) for rats injected with the labelled glucose alone or together with actinomycin D, and the rates of change derived from these plots are given in Table 3 . By extrapolation of the plots the glucose concentration at the time of injection was obtained and used to calculate the glucose space (Table 3) . For glucagon-injected rats, which showed no significant fall in plasma glucose concentration (Fig. 1) , the mean value was used to calculate the glucose space (Table 3) .
The logarithm ofthe specific radioactivity ofplasma glucose decreased linearly with time for both Table 3 . Effect ofactinomycin D andglucagon on the glucose pool, the glucose space and the rates offormation and utilization ofglucose in caesarian-delivered newborn rats The results were calculated as described in the text from the plasma glucose specific-radioactivity decay results after the intraperitoneal injection of [6-14C]glucose (4,uCi/IOOg body wt.) and [6_3H]glucose either alone or simultaneously with actinomycin D (50,ug/lOOg body wt.) or glucagon (50,ug/rat) into caesarian-delivered newborn rats at delivery. Each specific-radioactivity measurement was made on the plasma pooled from three animals. Statistically significant differences from untreated animals: *** P<0.001; ** P<0.01; * P<0.05. (Table 3) expressed per 100g body wt., and obtained by using the results for both [6-14C]-and [6-3H]-glucose, were in fairly good agreement for each of the experimental groups. The pool size in the glucagon-treated rats was slightly higher than that in the untreated controls (P<0.05), as was the glucose space (P<0.05).
The rate of glucose formation was significantly increased (P<0.05) in rats injected with glucagon at birth, but even more pronounced was the effect on glucose utilization, which was significantly decreased (P<0.01) ( Table 3) . Both of these effects will contribute to the observed stabilization of plasma glucose concentrations in newborn rats injected with glucagon (Fig. 1) . Actinomycin D injection completely prevented glucose formation (P<0.001) in rats at birth and also decreased the rate of glucose utilization (P<0.01) ( Table 3 ).
I.Ir (96) . For each of the experimental situations, the weight did not vary significantly between the groups of rats killed at each time-interval after injection. The decrease in the logarithm of the concentration of plasma lactate with time ( Fig. 2) was linear in each of the experimental situations (P<0.01 or better) and the rates of change are recorded in Table 4 . The decrease in plasma lactate concentration in rats injected with glucagon was significantly greater than in untreated controls (P<0.01) (Fig. 2 , Table 4 ). The lactate pool and lactate space in the glucagon-treated rats were somewhat greater than in untreated animals (P<0.05), but were not significantly different (P>0.05) in the animals injected with actinomycin D (Table 4) .
After the injection of the tracer dose of [U-14C]-lactate into newborn rats, the logarithm ofthe specific radioactivity ofplasma lactate decreased linearly with time (P<0.001) over the period of the experiment in each ofthe experimental situations. The rate oflactate formation in animals treated with glucagon or actinomycin D was not significantly different from that in untreated rats, but the rate of lactate utilization was stimulated significantly in the glucagon-treated animals (P<0.01) ( Table 4 ). The incorporation of 14C into plasma glucose after [U-14C]lactate injection into newborn rats in the different experimental situations is shown in Fig. 3 . Glucagon treatment markedly stimulated incorporation into plasma glucose, whereas actinQmycin D decreased the lactate incorporation.
Discussion
The suggestion that there is a delay in hepatic glycogenolysis in the immediately newborn rat (Snell & Walker, 1973 ) is strengthened by the present results. The glycogenolytic agents glucagon or dibutyryl cyclic AMP resulted in a pronounced mobilization of tions (Table 1 ). An apparent block in hepatic glycogenolysis in late foetal rats in utero after maternal starvation was also reported by Goodner & Thompson (1967) , and Gennser et al. (1971) found a similar situation in the human foetus at mid-gestation during acute intra-uterine asphyxia. On the other hand, Greengard & Dewey (1970) and Hunter (1969) reported a pronounced glycogenolytic response to an intra-uterine injection of glucagon in foetal rats in late gestation. The dibutyryl analogue of cyclic AMP exactly mimicked the observed effects of glucagon on hepatic glycogenolysis and plasma glucose concentrations (Table 1 ). The inability of glucagon to promote liver glycogen breakdown in the first 2h after delivery does not therefore appear to be caused by a lack of effect of the hormone on cyclic AMP production. Indeed measurements in vitro of the activation of adenylate cyclase (which catalyses cyclic AMP formation) by glucagon at birth, as well as the basal activity of the enzyme at that time, indicate properties very similar to those of the enzyme in adult liver (Hommes & Berre, 1971; Bar & Hahn, 1971) .
Hepatic glycogen mobilization in adult rats is effected by activation of ao-glucan phosphorylase (Sutherland & Rall, 1960; Hers et al., 1970) and this enzyme is present in rat liver at birth at about the same activity as in the adult (Dawkins, 1963a (Dawkins, 1963a) . Similarly, no change in phosphorylase activity was observed during asphyxia in the human foetal liver, nor could phosphorylase activation by adrenaline be demonstrated in vitro (Gennser et al., 1971) . The high plasma glucose concentrations in the newborn rat immediately at birth (Snell & Walker, 1973) may be a contributory factor towards the apparent lack ofphosphorylase activation at this time. Glucose inhibits phosphorylase activity in vitro (Buschiazzo et al., 1970; Maddaiah & Madsen, 1966; Hers et al., 1970; de Wulf, 1971; Bailey & Whelan, 1972) and hyperglycaemia can cause a rapid inactivation of phosphorylase in adult rat liver (Glinsmann et al., 1970) . Adrenalectomy is also known to block the stimulation of phosphorylase activity and glycogenolysis by cyclic AMP in adult rat liver in vivo (Schaeffer et al., 1969a) and in vitro (Exton et al., 1972) , and adrenalectomy at birth caused a 30% decrease in the normal activation of phosphorylase at 3h post partum (Cake & Oliver, 1969) . Table 2 shows that cortisol injected with dibutyryl cyclic AMP at delivery had no effect on liver glycogen concentrations, but injected together at 1 h post partum these agents promoted a marked glycogenolysis. It may be that a relative adrenal corticosteroid insufficiency at birth contributes in part to the delay in glycogen mobilization in the newborn rat. Plasma corticosterone concentrations show a prenatal peak at 18-20 days gestation and then decrease to low values on the last 2 days of gestation and in the immediately newborn rat, before rising again to reach values similar to the prenatal peak value at 2hpostpartum (Holt & Oliver, 1968) . Schapiro et al. (1962) and Levine et al. (1967) have shown that in newborn rats, in contrast with adults, corticosterone concentrations do not rise in response to stress.
Despite the lack of effect of glucagon or dibutyryl cyclic AMP on liver glycogen concentrations at birth, plasma glucose concentrations were elevated by these agents (Table 1, Fig. 1 ). Estimates of rates of glucose formation and utilization after glucagon treatment revealed an enhancement of glucose formation and a decrease in glucose utilization (Table 3 ). The high rate of glucose utilization in the untreated newborn animal (Table 3 ; see also Snell & Walker, 1973) is probably due to the high concentration of plasma insulin at this time (Blazquez et al., 1970) ; glucagon may antagonize the effects of insulin in some way so as to decrease glucose utilization.
The increased rate of glucose formation observed after glucagon injection into newborn rats (Table 3) is accompanied by a simultaneous increase in the rate of lactate utilization and in the rate of fall of plasma lactate concentrations with time ( (Fig. 3 ). An increased incorporation of [3-'4C]pyruvate into glycogen in liver slices and in vivo after glucagon injection into 21-dayold rat foetuses has been observed by Philippidis & Ballard (1970) and this was accompanied by a marked fall in the hepatic lactate concentration. The effects of exogenous glucagon on metabolism of glucose and lactate observed in the present study may be of physiological significance with regard to the normally developing newborn rat, since plasma glucagon concentrations have been shown by Girard et al. (1972) to be elevated maximally at 30min after birth. The elevation of plasma glucose concentrations by dibutyryl cyclic AMP in the first hour after birth was blocked by the simultaneous administration ofactinomycin D (Table 1 ). The rise in plasma glucose concentration ( Fig. 1 ) and the increased rate of glucose formation (Table 3 ; Fig. 3 ) after glucagon treatment at this time probably therefore requires the production of RNA and the induced synthesis of one or more enzymes involved in gluconeogenesis. Although it is not possible to identify unequivocally the entity that is involved in the increased rate of gluconeogenesis, it is generally accepted that phosphopyruvate carboxylase (EC 4.1.1.32) is the rate-limiting enzyme in this pathway at birth (Ballard & Hanson, 1967; Philippidis & Ballard, 1969; Ballard, 1971) . Glucagon or dibutyryl cyclic AMP markedly stimulate phosphopyruvate carboxylase activity in utero, in the immediately newborn rat and in foetal liver explants Yeung & Oliver, 1968a,b; Cake et al., 1971; Philippidis & Ballard, 1970; Wicks, 1969) and this induction is blocked by actinomycin D and by inhibitors of protein synthesis.
The lack of effect of actinomycin D on the dibutyryl cyclic AMP-stimulated increase in plasma glucose concentrations in the third hour after delivery (Table 1) is consistent with the suggestion that the hyperglycaemia at this time is due primarily to stimulation of hepatic glycogenolysis (as judged by the decrease in liver glycogen concentrations, Table 1 ), since the increase in phosphorylase activity, which is presumed to be responsible for the glycogen breakdown, is an activation phenomenon that is insensitive to actinomycin D or puromycin (Sutherland & Rall, 1960; Cake & Oliver, 1969) .
Actinomycin D also blocked the natural development of gluconeogenesis during the first hour after birth on the basis of measurements of glucose formation (Table 3) and of "4C incorporation from [14C]-lactate into plasma glucose (Fig. 3) . One consequence of this is to accelerate the development of hypoglycaemia immediately after delivery (Fig. 1 ). This effect of actinomycin D suggests that the normal development of gluconeogenesis in the immediately newborn rat is dependent at least on the synthesis of RNA and protein. Inhibition of the synthesis of phosphopyruvate carboxylase by actinomycin D is likely, since it has been shown by immunochemical-precipitation methods that the rate of synthesis of this enzyme increases fivefold within the first 2h after delivery (Philippidis et al., 1972) , and both actinomycin D and puromycin inhibit the natural rise in phosphopyruvate carboxylase activity that occurs immediately after delivery (Yeung & Oliver, 1968b; Cake et al., 1971) . The interpretation of the results obtained with actinomycin D must, of course, be viewed with some caution in the absence ofa complete understanding of the action of the inhibitor in this situation.
